betamethasone-17,21-dipropionate has been researched along with Pain in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Kircik, C; Kircik, L | 1 |
Chen, H; Diao, Q; Gao, Y; Geng, L; He, C; He, Y; Hu, F; Ji, C; Jin, H; Jing, H; Li, L; Li, X; Li, Y; Liu, X; Lu, Q; Lu, T; Lv, C; Miao, G; Shi, J; Shi, Y; Song, J; Wang, R; Wang, X; Wang, Y; Xia, J; Xia, X; Yan, M; Yang, X; Zhang, L; Zhang, R; Zhang, S; Zhang, X; Zheng, M; Zhou, X | 1 |
Balato, A; Caterino, P; Cirillo, T; Dente, V; Gallo, L; Lodi, G; Megna, M; Mozzillo, R | 1 |
1 trial(s) available for betamethasone-17,21-dipropionate and Pain
Article | Year |
---|---|
Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study.
Topics: Emollients; Humans; Pain; Patient Preference; Pilot Projects; Psoriasis | 2023 |
2 other study(ies) available for betamethasone-17,21-dipropionate and Pain
Article | Year |
---|---|
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatologic Agents; Drug Combinations; Erythema; Female; Humans; Male; Middle Aged; Nicotinic Acids; Pain; Prospective Studies; Pruritus; Psoriasis; Recurrence; Retreatment; Severity of Illness Index; Skin Cream | 2021 |
Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.
Topics: Administration, Topical; Adult; Aerosols; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Hand; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Prospective Studies; Psoriasis; Severity of Illness Index; Young Adult | 2019 |